Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema

NCT00701181 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

184

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Diabetic Retinopathy
Diabetes Complications

Interventions

PROCEDURE: Laser Treatment
DRUG: PF-04523655 high
DRUG: PF-04523655 middle
DRUG: PF-04523655 low

Sponsor

Quark Pharmaceuticals

Collaborators

[object Object]